Viewing Study NCT02358356


Ignite Creation Date: 2025-12-24 @ 11:36 PM
Ignite Modification Date: 2026-02-22 @ 7:02 AM
Study NCT ID: NCT02358356
Status: COMPLETED
Last Update Posted: 2022-07-05
First Post: 2014-11-04
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Capecitabine ON Temozolomide Radionuclide Therapy Octreotate Lutetium-177 NeuroEndocrine Tumours Study
Sponsor: Australasian Gastro-Intestinal Trials Group
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module